RPG Life Sciences Ltd (RPGLIFE) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 456242, "name": "RPG LifeScience.", "stock_name": "RPG LifeScience.", "full_name": "RPG Life Sciences Ltd", "name_url": "stocks-analysis/rpg-lifescience", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "2,386.10", "chg": 65.6, "chgp": "2.83%", "dir": 1, "prev_price": "2,320.50", "mcapval": "3,826.00 Cr", "mcap": "Small Cap", "scripcode": 532983, "symbol": "RPGLIFE", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE105J01010", "curr_date": "May 06", "curr_time": "", "bse_nse_vol": "26.13 k", "exc_status": "Active", "traded_date": "May 06, 2026", "traded_date_str": "2026 05 06", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/rpg-lifescience-456242-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "RPG Life Sciences Ltd Upgraded to Hold as Financial and Technical Trends Shift", "link": "https://www.marketsmojo.com/news/stock-recommendation/rpg-life-sciences-ltd-upgraded-to-hold-as-financial-and-technical-trends-shift-3977119", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/RPGLifeSciences_mojoScore_3977119.png", "date": "2026-05-06 08:19:51", "description": "RPG Life Sciences Ltd has seen its investment rating upgraded from Sell to Hold as of 5 May 2026, reflecting a nuanced shift in its financial performance, valuation metrics, and technical indicators. Despite some challenges, the company’s improved quarterly profits, cash reserves, and mildly bullish technical signals have contributed to this reassessment, signalling cautious optimism for investors in the pharmaceuticals and biotechnology sector." }, { "title": "RPG Life Sciences Ltd Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/rpg-life-sciences-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3976807", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/RPGLifeSciences_technicaldot_3976807.png", "date": "2026-05-06 08:02:07", "description": "RPG Life Sciences Ltd has witnessed a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance, despite a day’s decline of 4.26% to close at ₹2,320.50. This transition is underscored by a complex interplay of technical indicators, reflecting both optimism and caution among investors in the Pharmaceuticals & Biotechnology sector." }, { "title": "RPG Life Sciences Ltd Sees Mixed Technical Signals Amid Price Momentum Shift", "link": "https://www.marketsmojo.com/news/stocks-in-action/rpg-life-sciences-ltd-sees-mixed-technical-signals-amid-price-momentum-shift-3974751", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/RPGLifeSciences_technicaldot_3974751.png", "date": "2026-05-05 08:02:41", "description": "RPG Life Sciences Ltd has experienced a notable shift in price momentum, reflected in a 5.50% gain on 5 May 2026, closing at ₹2,423.80. Despite this surge, technical indicators present a nuanced picture, with mixed signals across weekly and monthly timeframes, prompting a reassessment of the stock’s outlook within the Pharmaceuticals & Biotechnology sector." }, { "title": "RPG Life Sciences Surges 12.67% Amid Profit Recovery and Intraday Highs", "link": "https://www.marketsmojo.com/news/stocks-in-action/rpg-life-sciences-surges-1267-amid-profit-recovery-and-intraday-highs-3971826", "imagepath": "", "date": "2026-05-02 17:08:10", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>27 Apr:</strong> Stock opens at Rs.2,009.85, declines 1.43%</p>\n <p><strong>28 Apr:</strong> Rebounds with 2.43% gain to Rs.2,058.75</p>\n <p><strong>29 Apr:</strong> Pullback of 1.76% amid broader market gains</p>\n <p><strong>30 Apr:</strong> Intraday high and surge of 12.51% to Rs.2,297.45 on strong volume and Q4 results</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,039.05</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs...." }, { "title": "Are RPG Life Sciences Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-rpg-life-sciences-ltd-latest-results-good-or-bad-3970736", "imagepath": "", "date": "2026-04-30 19:16:24", "description": "RPG Life Sciences Ltd's latest financial results for Q4 FY26 present a mixed picture. The company reported a net profit of ₹29.90 crores, reflecting a sequential recovery with a notable increase of 35.11% compared to the previous quarter. However, this figure represents a decline of 14.40% year-on-year, indicating challenges in sustaining profitability over a longer period.\n\nIn terms of net sales, RPG Life Sciences recorded ₹176.89 crores, which is a slight decrease of 1.74% from the prior quarter but shows a modest year-on-year growth of 2.42%. This tepid revenue growth raises concerns about the company's ability to expand its market share effectively within the competitive pharmaceutical sector.\n\nThe operating margin, excluding other income, was reported at 18.56%, which marks a significant contraction of 350 basis points from the previous quarter and a more substantial decline from the same quarter last ..." }, { "title": "RPG Life Sciences Q4 FY26: Profit Recovery Masks Margin Erosion Concerns", "link": "https://www.marketsmojo.com/news/result-analysis/rpg-life-sciences-q4-fy26-profit-recovery-masks-margin-erosion-concerns-3970198", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/RPGLifeSciences_quaterlyResult_3970198.png", "date": "2026-04-30 09:46:38", "description": "RPG Life Sciences Ltd., a Mumbai-based pharmaceutical manufacturer with a market capitalisation of ₹3,706.48 crores, reported a sequential profit recovery in Q4 FY26, but the headline numbers conceal troubling margin erosion and muted revenue growth. The company posted a consolidated net profit of ₹29.90 crores for the quarter ended March 2026, marking a robust 35.11% quarter-on-quarter improvement from ₹22.13 crores in Q3 FY26. However, on a year-on-year basis, profits declined 14.40% from ₹34.93 crores in the corresponding quarter of the previous year, raising questions about the sustainability of the company's earnings trajectory." }, { "title": "RPG Life Sciences Ltd Surges 12.5% to Day's High of Rs 2232 — Outperforms Sector by 10.8 Percentage Points", "link": "https://www.marketsmojo.com/news/stocks-in-action/rpg-life-sciences-ltd-hits-intraday-high-with-1251-surge-on-30-april-2026-3969754", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/RPGLifeSciences_priceRelatedfactors_3969754.png", "date": "2026-04-30 09:45:57", "description": "The Sensex declined by 1.05% on 30 Apr 2026, while RPG Life Sciences Ltd surged 12.51%, outperforming its Pharmaceuticals & Biotechnology sector by nearly 11 percentage points. This sharp single-session gain stands out as a clear stock-specific event amid a broadly weak market environment." }, { "title": "RPG Life Sciences Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/rpg-life-sciences-ltd-is-rated-sell-3966541", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/RPGLifeSciences_mojoScore_3966541.png", "date": "2026-04-28 10:10:03", "description": "RPG Life Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing." }, { "title": "When is the next results date for RPG Life Sciences Ltd?", "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-rpg-life-sciences-ltd-3959887", "imagepath": "", "date": "2026-04-23 23:16:23", "description": "The next results date for RPG Life Sciences Ltd is scheduled for April 29, 2026...." } ], "total": 360, "sid": "456242", "stock_news_url": "https://www.marketsmojo.com/news/rpg-life-sciences-456242" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome", "datetime": "30-Apr-2026", "details": "The Company has informed about the recording of Earnings Call.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation", "datetime": "30-Apr-2026", "details": "Investor Presentation", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "30-Apr-2026", "details": "Newspaper Publication", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "RPG Life Sciences Ltd has declared <strong>250%</strong> dividend, ex-date: 27 Jun 25", "dt": "2025-06-27", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

27 Apr: Stock opens at Rs.2,009.85, declines 1.43%

28 Apr: Rebounds with 2.43% gain to Rs.2,058.75

29 Apr: Pullback of 1.76% amid broader market gains

30 Apr: Intraday high and surge of 12.51% to Rs.2,297.45 on strong volume and Q4 results

Read full news article

Are RPG Life Sciences Ltd latest results good or bad?

2026-04-30 19:16:24

RPG Life Sciences Ltd's latest financial results for Q4 FY26 present a mixed picture. The company reported a net profit of ₹29.90 crores, reflecting a sequential recovery with a notable increase of 35.11% compared to the previous quarter. However, this figure represents a decline of 14.40% year-on-year, indicating challenges in sustaining profitability over a longer period. In terms of net sales, RPG Life Sciences recorded ₹176.89 crores, which is a slight decrease of 1.74% from the prior quarter but shows a modest year-on-year growth of 2.42%. This tepid revenue growth raises concerns about the company's ability to expand its market share effectively within the competitive pharmaceutical sector. The operating margin, excluding other income, was reported at 18.56%, which marks a significant contraction of 350 basis points from the previous quarter and a more substantial decline from the same quarter last ...

Read full news article

RPG Life Sciences Q4 FY26: Profit Recovery Masks Margin Erosion Concerns

2026-04-30 09:46:38

RPG Life Sciences Ltd., a Mumbai-based pharmaceutical manufacturer with a market capitalisation of ₹3,706.48 crores, reported a sequential profit recovery in Q4 FY26, but the headline numbers conceal troubling margin erosion and muted revenue growth. The company posted a consolidated net profit of ₹29.90 crores for the quarter ended March 2026, marking a robust 35.11% quarter-on-quarter improvement from ₹22.13 crores in Q3 FY26. However, on a year-on-year basis, profits declined 14.40% from ₹34.93 crores in the corresponding quarter of the previous year, raising questions about the sustainability of the company's earnings trajectory.

Read full news article

RPG Life Sciences Ltd Surges 12.5% to Day's High of Rs 2232 — Outperforms Sector by 10.8 Percentage Points

2026-04-30 09:45:57

The Sensex declined by 1.05% on 30 Apr 2026, while RPG Life Sciences Ltd surged 12.51%, outperforming its Pharmaceuticals & Biotechnology sector by nearly 11 percentage points. This sharp single-session gain stands out as a clear stock-specific event amid a broadly weak market environment.

Read full news article

RPG Life Sciences Ltd is Rated Sell

2026-04-28 10:10:03

RPG Life Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

When is the next results date for RPG Life Sciences Ltd?

2026-04-23 23:16:23

The next results date for RPG Life Sciences Ltd is scheduled for April 29, 2026....

Read full news article